ETON Return on Tangible Equity | Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. (ETON) Return on Tangible Equity

2026-06-30: Return Tang Equity 1398.90%.
2026-03-31: Return Tang Equity 11.24%.
2025-12-31: Return Tang Equity 97.40%.
2025-09-30: Return Tang Equity 76.35%.

Complete source-backed return tang equity history.

Available history: 2018-09-30 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	1398.90%
2026-03-31	11.24%
2025-12-31	97.40%
2025-09-30	76.35%
2025-06-30	46.29%
2025-03-31	48.61%
2024-12-31	36.57%
2024-09-30	-54.12%
2024-06-30	-91.10%
2024-03-31	10.03%
2023-12-31	-8.72%
2023-09-30	17.60%
2023-06-30	-1.90%
2023-03-31	-95.25%
2022-12-31	-108.37%
2022-09-30	-143.27%
2022-06-30	-117.85%
2022-03-31	-135.63%
2021-12-31	-11.09%
2021-09-30	-68.21%
2021-06-30	-53.49%
2021-03-31	-64.05%
2020-12-31	-158.65%
2020-09-30	-1655.55%
2020-06-30	-304.94%
2020-03-31	-187.94%
2019-12-31	-173.65%
2019-09-30	-156.74%
2019-06-30	-103.59%
2019-03-31	-89.03%
2018-12-31	-48.44%
2018-09-30	71.98%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	97.40%
2024-12-31	36.57%
2023-12-31	-8.72%
2022-12-31	-108.37%
2021-12-31	-11.09%
2020-12-31	-158.65%
2019-12-31	-173.65%
2018-12-31	-48.44%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Xencor Inc (XNCR)	United States	$1.776B	-7.33
Rapport Therapeutics, Inc. (RAPP)	United States	$1.623B	-14.56
Septerna, Inc. (SEPN)	United States	$1.783B	-63.01
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82
ANI PHARMACEUTICALS INC (ANIP)	United States	$1.810B	18.77
COMPASS Pathways plc (CMPS)		$1.812B	-4.87
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20